Today's Rundown Regeneron's Praluent sidekick moves the needle on 'bad' cholesterol D&D bags $137M to fund midphase Alzheimer's, Parkinson's trials Renovacor bags $11M to push precision medicine for rare heart disease Zeldin joins Immunovant as CMO months after Acceleron split FDA cancer office taps Syapse for real-world evidence development Featured Story | | | Wednesday, August 14, 2019 Patients with high cholesterol stemming from a rare genetic disorder struggle to keep their cholesterol levels under control despite taking lipid-busting drugs such as statins and PCSK9 inhibitors. A new drug from Regeneron may change that. |
|
|
Top Stories Wednesday, August 14, 2019 D&D Pharmatech has raised $137.1 million to advance treatments for neurodegenerative diseases and fibrosis. The series B will enable one D&D subsidiary to run phase 2 trials in Alzheimer's and Parkinson’s. Wednesday, August 14, 2019 Renovacor is working on a gene therapy for a small group of patients with dilated cardiomyopathy, a potentially fatal heart disease. The treatment could ward off disease progression and spare those patients from a heart transplant. Wednesday, August 14, 2019 Immunovant has named Robert Zeldin as its chief medical officer. Zeldin, who last worked as CMO of Acceleron Pharma, arrives at Immunovant shortly after it moved its lead drug into phase 2 trials in two indications. Wednesday, August 14, 2019 Healthcare data firm Syapse has begun working with the FDA to help bring real-world evidence to bear on the agency’s decisions to approve cancer drugs. Resources Sponsored by: Wesco Pharmaceutical Solutions and WBR Insights The regulations and managing processes for hazardous, controlled and rare chemicals and biologics necessary for drug discovery are a huge distraction for R&D labs. Learn from the perspectives of industry executives the pain points and improvements they want in their processes for chemicals and biologics in pharmaceuticals R&D. Sponsored by: Kinaxis Download this life sciences industry spotlight to discover how concurrent planning can help you overcome complex supply chain challenges to drive down costs and improve efficiency. Sponsored by: Patheon, by Thermo Fisher Scientific Patheon, part of Thermo Fisher Scientific, offers advanced API manufacturing technologies such as continuous processing and continuous analytics to deliver high-quality products with well-defined features to meet your timelines and volume requirements. Sponsored by: ICON Understanding the challenges for formulary decision makers and manufacturers. Sponsored by: Veeva This white paper details how leveraging new reporting capabilities, live UAT feedback sessions, and an agile design approach to study builds will save them time and money. Sponsored by: BBK Worldwide The Study Voices survey challenges the myth that physicians won’t refer patients to clinical trials, and it identifies opportunities to engage physicians as partners in the enrollment process. Sponsored by: Cambrex The highest number of NCEs approved by the FDA…the fastest growing small molecule clinical pipeline reported in 20 years…these are exciting times for our industry. Sponsored by: Reprints Desk, Inc. Cut your research time in half - with an easy-to-use app for scientists that combines full-featured reference management with integrated search and on-demand document delivery. Sponsored by: XiltriX North America Find out in this article how your pharmaceutical organization can leverage IoT technologies and informatics integration to innovate and improve overall operational efficiencies. Sponsored by: Catalent Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study. Sponsored by: Catalent Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels. Sponsored by: Catalent Download the eBook to explore a proactive approach for clinical supply management. Latin America Healthcare Compliance Certificate Program September 23-26, 2019 4th FierceBiotech Drug Development Forum October 28-29, 2019 | Boston, MA Drug Development Boot Camp® 2019 November 20-21, 2019 | Boston, MA | Register NOW and start Pre-Boot Camp Preparation! | 